Abstract
An EBNA1-specific small molecule (JLP2) has been synthesised. As a strong binder and dimerization inhibitor of EBNA1 in vitro, JLP2 may be used as a selective luminescent agent for the imaging and inhibition of latent EBV-infected cancer cells.
Original language | English |
---|---|
Pages (from-to) | 6517-6519 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 50 |
Issue number | 49 |
Early online date | 28 Mar 2014 |
DOIs | |
Publication status | Published - 21 Jun 2014 |
Scopus Subject Areas
- Catalysis
- Electronic, Optical and Magnetic Materials
- Ceramics and Composites
- General Chemistry
- Surfaces, Coatings and Films
- Metals and Alloys
- Materials Chemistry